Skip to main content
. 2022 Dec 7;2022(12):CD015477. doi: 10.1002/14651858.CD015477
Study  Intervention name Estimate effect Unit of analysis  Time point Type of assay  Population
GMT (95% CI) GMR (95% CI)
Heterologous boost versus homologous boost
Li 2021a
 
CoronaVac/Ad5 boost 197.40 
(167.70 to 232.40)
5.87 (4.64 to 7.43) BAU/mL 14 days after boost ELISA RBD‐binding IgG 18–59 years
CoronaVac/CoronaVac boost 33.60 
(28.30 to 39.80)